Correlation Between Takeda Pharmaceutical and Cardiol Therapeutics
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Takeda Pharmaceutical and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Cardiol Therapeutics.
Diversification Opportunities for Takeda Pharmaceutical and Cardiol Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Takeda and Cardiol is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Cardiol Therapeutics go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Cardiol Therapeutics
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.29 times more return on investment than Cardiol Therapeutics. However, Takeda Pharmaceutical Co is 3.42 times less risky than Cardiol Therapeutics. It trades about -0.1 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about -0.12 per unit of risk. If you would invest 1,394 in Takeda Pharmaceutical Co on September 1, 2024 and sell it today you would lose (32.00) from holding Takeda Pharmaceutical Co or give up 2.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Takeda Pharmaceutical Co vs. Cardiol Therapeutics Class
Performance |
| Timeline |
| Takeda Pharmaceutical |
| Cardiol Therapeutics |
Takeda Pharmaceutical and Cardiol Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Takeda Pharmaceutical and Cardiol Therapeutics
The main advantage of trading using opposite Takeda Pharmaceutical and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.| Takeda Pharmaceutical vs. Crinetics Pharmaceuticals | Takeda Pharmaceutical vs. Enanta Pharmaceuticals | Takeda Pharmaceutical vs. Amicus Therapeutics | Takeda Pharmaceutical vs. Connect Biopharma Holdings |
| Cardiol Therapeutics vs. Flora Growth Corp | Cardiol Therapeutics vs. ABVC Biopharma | Cardiol Therapeutics vs. Indaptus Therapeutics | Cardiol Therapeutics vs. HCW Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |